
The associate professor from UC San Diego discussed promising efficacy and safety data from a phase 1/2 trial.
The associate professor from UC San Diego discussed promising efficacy and safety data from a phase 1/2 trial.
The associate professor from UC San Diego discussed the ongoing phase ½ trial of CTNS-RD
The associate professor from UC San Diego discussed the curative potential of gene therapy in cystinosis.
Published: February 14th 2022 | Updated: